{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:22:22Z","timestamp":1778808142092,"version":"3.51.4"},"reference-count":47,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s256714","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T02:57:17Z","timestamp":1599620237000},"page":"499-504","source":"Crossref","is-referenced-by-count":15,"title":["<p>OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-3724","authenticated-orcid":true,"given":"Nat","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake","family":"Hard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-8067","authenticated-orcid":true,"given":"Colin","family":"Fearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-8378","authenticated-orcid":true,"given":"Mark","family":"Gilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-4995","authenticated-orcid":true,"given":"Luxman","family":"Parimelalagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrukh","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1409722","volume":"00","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1747-597X-8-35","volume":"8","author":"Lang","year":"2013","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref3","unstructured":"HM Inspectorate of Prisons. Changing patterns of substance misuse in adult prisons and service responses. 2015."},{"key":"ref4","unstructured":"World Health Organization. Regional Office for Europe. Preventing overdose deaths in the criminal-justice system. 2014."},{"key":"ref5","unstructured":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Global and Public Health\/Population Health\/Healthy Behaviours\/25460; 2017."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Coid J, Carvell A, Kittler Z, Healey A, Henderson J Opiates, criminal behaviour, and methadone treatment. 2000.","DOI":"10.1037\/e665482007-001"},{"key":"ref7","volume-title":"Handbook on Prisons","year":"2016"},{"key":"ref8","unstructured":"Cooper R, Labour MP, Lancashire W House of commons health and social care committee. Prison health. Twelfth Report of Session 2017\u201319. 2018;November."},{"key":"ref9","unstructured":"Northamptonshire Healthcare NHS Foundation Trust. MMPr027\/HMP controlled drug procedure for HMP bedford.; 2018."},{"key":"ref10","unstructured":"RCGP Secure Environments Group. Safer prescribing in prisons. Guidance for clinicians. 2011."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Nielsen S, Degenhardt L, Larance B, Gowing L, Kehler C, Lintzeris N Opioid agonist treatment for pharmaceutical opioid dependent people (protocol). 2016. doi:10.1002\/14651858.CD011117","DOI":"10.1002\/14651858.CD011117"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2.www.cochranelibrary.com","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1477-7517-7-17","volume":"7","author":"St\u00f6ver","year":"2010","journal-title":"Harm Reduct J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugalcdep.2016.11.032","volume":"171","author":"Bi-Mohammed","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref15","unstructured":"Webster R Service user views on Opioid Substitute Treatment in Prison and on Release."},{"key":"ref16","unstructured":"Public Health England. Secure setting statistics from the National Drug Treatment Monitoring System (NDTMS). 2017."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/add.13803","volume":"112","author":"Bukten","year":"2017","journal-title":"Addiction"},{"key":"ref18","unstructured":"European Medicines Agency. Buvidal Buprenorphine, Summary of Opinion (Initial Authorisation). 2018."},{"key":"ref19","unstructured":"National Institute for Health and Care Excellence. Evidence review. Opioid dependence: buprenorphine prolonged-release injection (Buvidal). 2019."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamainternmed.2018.1052","volume":"178","author":"Lofwall","year":"2018","journal-title":"JAMA Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/add.14636","author":"Frost","year":"2019","journal-title":"Addiction"},{"key":"ref22","unstructured":"University of Vermont. Opioid epidemic linked to childhood emotional abuse, study shows Findings suggests new treatment approaches for opioid abusers. ScienceDaily. 2017. doi:10.1016\/j.ad"},{"key":"ref23","unstructured":"Healthcare Improvement Scotland. SMC 2169 buprenorphine 8\/16\/24\/32\/64\/96\/128mg prolonged-release solution for injection (Buvidal \u00ae). 2019;(August):1\u201313."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/17425247.2019.1649252","volume":"16","author":"Vorspan","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"ref25","unstructured":"National Institute for Health and Care Excellence. Evidence review opioid dependence: buprenorphine prolonged- release injection (Buvidal); 2019. https:\/\/www.nice.org.uk\/advice\/es19\/evidence\/evidence-review-pdf-6666819661. Accessed August 5, 2020."},{"key":"ref26","unstructured":"Dunlop A Depot buprenorphine for opioid dependence in prisons in NSW, Australia. Lisbon Addiction."},{"key":"ref27","unstructured":"Prison Health Services Methadone at HMP The Mount. Available from: https:\/\/bulger.co.uk\/prison\/methadoneblog.htm. Accessed August 10, 2020."},{"key":"ref28","unstructured":"Ministry of Justice. Population Bulletin: Monthly April 2019. 2019."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"NICE. TA 114 Methadone and buprenorphine for the management of opioid dependence. 2007. doi:10.2165\/11632820-000000000-00000","DOI":"10.2165\/11632820-000000000-00000"},{"key":"ref30","unstructured":"Expert communication. 2019."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"ref32","unstructured":"North East Ambulance Service NHS Foundation Trust. Freedom of Information Act 2000 \u2013 Information Request FOI.18.074. 2018."},{"key":"ref33","unstructured":"Prisons & Probation Ombudsman. Annual Report 2017 \u2013 18. 2018."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/add.13779","volume":"112","author":"Marsden","year":"2017","journal-title":"Natl Prospect Obs Study Engl"},{"key":"ref35","unstructured":"Ministry of Justice. Offender management statistics quarterly: adjudications. 2017."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"00158","DOI":"10.15406\/frcij.2017.05.00158","volume":"5","author":"O\u2019Hagan","year":"2017","journal-title":"Forensic Res Criminol Int J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/14659891.2014.904938","volume":"20","author":"Kopak","year":"2015","journal-title":"J Subst Use"},{"key":"ref38","unstructured":"NHS. NHS Electronic Drug Tariff. 2019."},{"key":"ref39","unstructured":"Medilogic UK. Personal communication. 2018."},{"key":"ref40","unstructured":"HM Prison & Probation Service. 10336 - Band 4 - Supervising Officer."},{"key":"ref41","unstructured":"Care UK. Staff Nurse vacancy."},{"key":"ref42","unstructured":"Care UK. Pharmacy Technician vacancy."},{"key":"ref43","unstructured":"Care UK. Pharmacist vacancy."},{"key":"ref44","unstructured":"NHS. Consultant Psychiatrist (Prison Service)."},{"key":"ref45","first-page":"204","volume":"2","author":"Scott","year":"2018","journal-title":"Justics Power Res"},{"key":"ref46","unstructured":"Ministry of Justice. Costs per Place and Costs per Prisoner by Individual Prison. 2018."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/13696998.2017.1325744","volume":"20","author":"Kenworthy","year":"2017","journal-title":"J Med Econ"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61291","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61291","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T02:57:37Z","timestamp":1599620257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/oud-care-service-improvement-with-prolonged-release-buprenorphine-in-p-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":47,"URL":"https:\/\/doi.org\/10.2147\/ceor.s256714","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}